about
The crystal structure of lipopolysaccharide binding protein reveals the location of a frequent mutation that impairs innate immunityTLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humansA coding mutation within the first exon of the human MD-2 gene results in decreased lipopolysaccharide-induced signalingLow frequency of the TIRAP S180L polymorphism in Africa, and its potential role in malaria, sepsis, and leprosy.Influence of genetic variations in TLR4 and TIRAP/Mal on the course of sepsis and pneumonia and cytokine release: an observational study in three cohortsVoluntary peer review as innovative tool for quality improvement in the intensive care unit--a retrospective descriptive cohort study in German intensive care unitsEarly deep sedation is associated with decreased in-hospital and two-year follow-up survivalThe German quality indicators in intensive care medicine 2013--second edition.Functional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by providing protection against septic shockGenetic influence on bloodstream infections and sepsis.Genetic variation in innate immunity pathways and their potential contribution to the SIRS/CARS debate: evidence from human studies and animal models.The course of gastric cancer following surgery is associated with genetic variations of the interleukin-1 receptor antagonist and interleukin-1β.Quality indicators in intensive care medicine for Germany - third edition 2017.Rapid molecular diagnosis of infective aortic valve endocarditis caused by Coxiella burnetii.Pre- and postoperative cytokine release after in vitro whole blood lipopolysaccharide stimulation and frequent toll-like receptor 4 polymorphisms.Massive subcutaneous emphysema after thoracoscopic argon beamer use for pleurodesis.
P50
Q24338277-65E7DFA9-CE8B-4953-8A81-FA7468FB2F87Q24678506-44079B3E-54AA-4726-A878-B2718592039FQ28253982-3953FC6F-679B-408B-A623-5924A94CE0C1Q33482057-70DB2951-AEFC-40FE-B097-2741571961ABQ34026949-9054143B-9146-47EB-9FFE-73939EEF0A20Q34730919-B64476D8-FE47-4E50-B7E8-331EB15BF87FQ35619773-99A49492-6B3B-4205-AEF2-24963DF7C2B4Q37058020-E1C985D8-4B11-4622-907E-4B3A15AA61B9Q37238784-910B6A4B-6BA9-4F4D-9548-412048FE2007Q37291989-820172E7-8976-4F20-8368-A8C378E08F24Q37739753-8C9D9DD7-016F-4F78-BBB0-41322A08AA5FQ39247168-31E5ED9C-6065-4910-8C3A-F668631FB082Q40099528-5A666722-1F19-4741-BEDE-8A279D7BFE5BQ40099878-95575A35-8696-4AEA-8325-6B70F11F947EQ52934205-F7C35D59-4CEB-437A-B884-20F0159CE40CQ52937326-A31FC6D8-557F-46B6-B9D9-A7116FEF5AC0
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Oliver Kumpf
@ast
Oliver Kumpf
@en
Oliver Kumpf
@es
Oliver Kumpf
@nl
type
label
Oliver Kumpf
@ast
Oliver Kumpf
@en
Oliver Kumpf
@es
Oliver Kumpf
@nl
prefLabel
Oliver Kumpf
@ast
Oliver Kumpf
@en
Oliver Kumpf
@es
Oliver Kumpf
@nl
P106
P21
P31
P496
0000-0001-7891-8872